Meilleure Health International Industry Group Limited 02327.HK 上一季度的收入表現如何?
Meilleure Health International Industry Group Limited 的收入預期是多少?
Meilleure Health International Industry Group Limited 的盈利品質評分是多少?
Meilleure Health International Industry Group Limited 何時發布財報?
Meilleure Health International Industry Group Limited 的預期收益是多少?
Meilleure Health International Industry Group Limited 是否超出收益預期?
關鍵數據
前收市價
--
開盤價
--
當日範圍
-
52週區間
-
交易量
--
平均成交量
2.1M
每股盈餘 (TTM)
0.01
股息收益率
--
市值
--
什麼是 MEILLEUREHEALTH?
Meilleure Health International Industry Group Ltd. engages in the research and sale of medicine and health care products, development of chemical and biological products, and multiple industrial investment and holdings. The company employs 49 full-time employees The company went IPO on 2003-10-14. The firm operates through four segments. The Healthcare-Related Business segment is engaged in health management services, medical beauty services, and sales of health-related products and Cannabidiol (CBD) downstream products. The Property-Related Business segment is engaged in real estate sales agency, investment property leasing, and residential property development and sales. The Trading Business segment is engaged in the trading of building materials and new energy products, the provision of new energy product procurement services, and health-related product sales agency services. The Equity Investment Business segment is engaged in the management of investment portfolio.